Abstract: There is disclosed a composition comprising cannabidiol (CBD) and one or more cannabinoids selected from cannabidiolic acid (CBDA), cannabigerol (CBG) and cannabigerolic acid (CBGA) for use in the treatment or prevention of inflammation and disorders associated with inflammation or an IL-6 related disorder.
Type:
Application
Filed:
February 8, 2022
Publication date:
April 18, 2024
Applicants:
TTS Pharma Ltd, Aberystwyth University
Inventors:
Robert WALTON, Mark TUCKER, Debbie NASH, Nathan ALLEN, Ruth WONFOR, Ifat SHAH